SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech fireworks
An SI Board Since October 2001
Posts SubjectMarks Bans
7424 222 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
6349And TGTX yet again, up 17% to new highs a couple of days after getting an SPA. tuck-9/17/2014
6348From the daily chart it's evident the news was not leakedtom pope-9/10/2014
6347NPSP +21% on FDA panel...mopgcw-9/10/2014
6346INFI 40 % on deal with ABBV Infinity Pharmaceutical and AbbVie (ABBV) announce sjemmeri-9/3/2014
6345KITE +28% after hours "The findings from an ongoing Phase 1-2a clinical tritnsaf-8/25/2014
6344Hansa Medical 22% "A successful kidney transplantation of an HLA sensitizenigel bates-8/18/2014
6343TKMR another +25% on 10X average volumetnsaf-8/11/2014
6342TKMR 38% on Ebola hype. (FDA allowing move from full to partial clinical hold.)nigel bates-8/8/2014
6341Onty 17.5% on Puma sympathies?mopgcw-7/23/2014
6340Any CLDX holders Here? .Rangle-6/26/2014
6339AERI gaps up on Glaucoma trial results bizjournals.comRon-6/25/2014
6338TGTX again.scaram(o)uche-6/24/2014
6337Cellectis 18% on this... (?) June 23, 2014 – Paris (France) – Cellectis (Alternnigel bates-6/24/2014
6336STEM +32% on results in dry AMD, but be careful: siliconinvestor.comDewDiligence_on_SI-6/19/2014
6335INSM 35% on breakthrough therapy designation for Arikayce.nigel bates-6/18/2014
6334June 18 (Reuters) - U.S. drugmaker Pfizer, which failed last month in a $118 bilnigel bates-6/18/2014
6333BIOL , a microcap, up 16% on heavy vol after CEO and Board changes, forced by OrSidney Street-6/17/2014
6332NWBO 16% on 3x avg volumeJohn McCarthy-6/16/2014
6331BLUE 80% premarket... Message 29582973nigel bates-6/16/2014
6330KPTI +23% - Karyopharm Announces First Combination Data of Selinexor With Low-Dotnsaf-6/13/2014
6329Karyopharm (KPTI) ~25% on P1 data presented at EHA. Small n, but good results. tuck-6/13/2014
6328NKTR +17%: Nektar Therapeutics confirms U.S. FDA advisory committee recommends ntnsaf16/13/2014
6327TGTX again.scaram(o)uche-6/12/2014
6326GERN, partial hold lifted siliconinvestor.comtom pope-6/12/2014
6325Synairgen 40%... Southampton, UK: Synairgen plc (LSE: SNG) today announced a glnigel bates-6/12/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News